<DOC>
	<DOC>NCT01014507</DOC>
	<brief_summary>This study is designed to test the the protective capacity of Goserelin compared with oral contraceptive</brief_summary>
	<brief_title>Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Advanced stage Hodgkins Lymphoma (histologically proven) Normal FSHlevels Written informed consent Hodgkins Lymphoma as "composite lymphoma" Primary ovarial dysfunction Age &gt; 40</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>